Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 1
2016 4
2017 1
2019 1
2022 1
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Uveal melanoma modeling in mice and zebrafish.
van den Bosch QCC, de Klein A, Verdijk RM, Kiliç E, Brosens E; Rotterdam Ocular Melanoma Study Group. van den Bosch QCC, et al. Biochim Biophys Acta Rev Cancer. 2024 Jan;1879(1):189055. doi: 10.1016/j.bbcan.2023.189055. Epub 2023 Dec 15. Biochim Biophys Acta Rev Cancer. 2024. PMID: 38104908 Free article. Review.
ATRX Loss in the Development and Prognosis of Conjunctival Melanoma.
van Ipenburg JA, van den Bosch QCC, Paridaens D, Dubbink HJ, Kiliç E, Naus N, Verdijk RM; Rotterdam Ocular Melanoma Study Group. van Ipenburg JA, et al. Int J Mol Sci. 2023 Aug 20;24(16):12988. doi: 10.3390/ijms241612988. Int J Mol Sci. 2023. PMID: 37629169 Free PMC article.
Uveal Melanoma Patients Have a Distinct Metabolic Phenotype in Peripheral Blood.
de Bruyn DP, Bongaerts M, Bonte R, Vaarwater J, Meester-Smoor MA, Verdijk RM, Paridaens D, Naus NC, de Klein A, Ruijter GJG, Kiliç E, Brosens E; Rotterdam Ocular Melanoma Study Group (ROMS). de Bruyn DP, et al. Int J Mol Sci. 2023 Mar 7;24(6):5077. doi: 10.3390/ijms24065077. Int J Mol Sci. 2023. PMID: 36982149 Free PMC article.
Multi-Modality Analysis Improves Survival Prediction in Enucleated Uveal Melanoma Patients.
Drabarek W, Yavuzyigitoglu S, Obulkasim A, van Riet J, Smit KN, van Poppelen NM, Vaarwater J, Brands T, Eussen B, Verdijk RM, Naus NC, Mensink HW, Paridaens D, Boersma E, van de Werken HJG, Kilic E, de Klein A; Rotterdam Ocular Melanoma Study Group. Drabarek W, et al. Invest Ophthalmol Vis Sci. 2019 Aug 1;60(10):3595-3605. doi: 10.1167/iovs.18-24818. Invest Ophthalmol Vis Sci. 2019. PMID: 31425584
Correlation of Gene Mutation Status with Copy Number Profile in Uveal Melanoma.
Yavuzyigitoglu S, Drabarek W, Smit KN, van Poppelen N, Koopmans AE, Vaarwater J, Brands T, Eussen B, Dubbink HJ, van Riet J, van de Werken HJ, Beverloo B, Verdijk RM, Naus N, Paridaens D, Kilic E, de Klein A; Rotterdam Ocular Melanoma Study Group. Yavuzyigitoglu S, et al. Ophthalmology. 2017 Apr;124(4):573-575. doi: 10.1016/j.ophtha.2016.10.039. Epub 2016 Dec 1. Ophthalmology. 2017. PMID: 27916271 No abstract available.
Metastatic Disease in Polyploid Uveal Melanoma Patients Is Associated With BAP1 Mutations.
Yavuzyigitoglu S, Mensink HW, Smit KN, Vaarwater J, Verdijk RM, Beverloo B, Brüggenwirth HT, van Marion R, Dubbink HJ, Paridaens D, Naus NC, de Klein A, Kiliç E; Rotterdam Ocular Melanoma Study Group (ROMS). Yavuzyigitoglu S, et al. Invest Ophthalmol Vis Sci. 2016 Apr 1;57(4):2232-9. doi: 10.1167/iovs.15-18608. Invest Ophthalmol Vis Sci. 2016. PMID: 27116551
Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.
Koopmans AE, Ober K, Dubbink HJ, Paridaens D, Naus NC, Belunek S, Krist B, Post E, Zwarthoff EC, de Klein A, Verdijk RM; Rotterdam Ocular Melanoma Study Group. Koopmans AE, et al. Invest Ophthalmol Vis Sci. 2014 Aug 26;55(9):6024-30. doi: 10.1167/iovs.14-14901. Invest Ophthalmol Vis Sci. 2014. PMID: 25159205
13 results